Lee D K, Cooper B T, Barbezat G O
N Z Med J. 1986 Aug 27;99(808):620-2.
Clostridium difficile toxin was isolated from the stools of three patients with chronic idiopathic colitis. Two patients were known to have chronic idiopathic colitis before Cl difficile toxin was isolated. The third patient was subsequently found to have ulcerative colitis after presentation with Cl difficile toxin in the stool. Two patients were on sulphasalazine at the time of diagnosis of Cl difficile infection and one had taken sulphasalazine two months previously. Only one patients had antibiotic exposure and that was at least three months before presentation. In each patient, treatment with vancomycin was accompanied by symptomatic improvement and disappearance of the toxin. The underlying colitis remained unaffected. In patients with inflammatory bowel disease in relapse, the presence of Cl difficile toxin should be sought as this may be a factor in the relapse. In any patient presenting with diarrhoea, the presence of Cl difficile toxin may obscure the presence of underlying inflammatory bowel disease.
艰难梭菌毒素是从三名慢性特发性结肠炎患者的粪便中分离出来的。在分离出艰难梭菌毒素之前,已知两名患者患有慢性特发性结肠炎。第三名患者在粪便中出现艰难梭菌毒素后,随后被发现患有溃疡性结肠炎。两名患者在诊断出艰难梭菌感染时正在服用柳氮磺胺吡啶,一名患者在两个月前服用过柳氮磺胺吡啶。只有一名患者有抗生素接触史,且至少在出现症状前三个月。在每名患者中,使用万古霉素治疗后症状改善且毒素消失。潜在的结肠炎未受影响。在炎症性肠病复发的患者中,应寻找艰难梭菌毒素的存在,因为这可能是复发的一个因素。在任何出现腹泻的患者中,艰难梭菌毒素的存在可能会掩盖潜在的炎症性肠病的存在。